Viewing Study NCT01009593


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2025-12-25 @ 11:16 PM
Study NCT ID: NCT01009593
Status: TERMINATED
Last Update Posted: 2012-09-10
First Post: 2009-10-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Sponsor: Abbott
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module